Suzhou Kebo Ruijun Biotechnology Co., Ltd
2 clinical trials · Sponsor
◉ Watch Suzhou Kebo Ruijun Biotechnology Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study to Evaluate JS019 in Advanced Solid Tumors or Lymphomas (NCT05374226) | Suzhou Kebo Ruijun Biotechnology Co., Ltd | 2022-03-31 |
| A Clinical Study to Evaluate the Safety, Tolerability,JS019 in Patients With Advanced Solid Tumors (NCT05508373) | Suzhou Kebo Ruijun Biotechnology Co., Ltd | 2022-03-29 |
Track Suzhou Kebo Ruijun Biotechnology Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.